Testosterone, sex hormone-binding globulin, and fracture risk in men: evidence from observational and Mendelian
Zhixiong Luo1,2, Anping Feng3, Anton Tyurin4
1School of Medicine, South China University of Technology, Guangzhou, 510006, China.
Abstract:
Both observational and factorial Mendelian randomization analysis revealed that the combined exposure to higher TT and lower SHBG was associated with decreased risk of fracture. These findings suggest that considering both TT and SHBG-rather than focusing on testosterone alone-may improve fracture risk assessment.
Purpose:
Lower total testosterone (TT) levels have been associated with increased fracture risk in aging men, yet the benefits of testosterone supplementation remain uncertain. This study aimed to assess the joint contributions of TT and sex hormone-binding globulin (SHBG) to fracture risk using both observational and genetic approaches.
Methods:
We included 162,786 men from the UK Biobank, with baseline serum TT and SHBG measurements and genetic data. Cox proportional hazards models were used to estimate associations of TT and SHBG with incident fractures. A 2 × 2 factorial Mendelian randomization (MR) analysis was conducted to evaluate the combined genetic effects of increased TT and decreased SHBG on fracture risk.
Results:
The median age at baseline was 59.0 years, and 7493 men experienced fractures during 13.3 years follow-up. The association between serum TT levels and incident fracture was significantly affected by adjustment for SHBG. Compared to the lowest quintile of Bio-T levels, the adjusted hazard ratio (HR) for total fracture in the highest quintile was 0.72 (95% CI: 0.67, 0.78). In factorial MR analysis, men with genetically higher TT and lower SHBG had significantly lower odds of total fracture (OR: 0.87, 95% CI: 0.80-0.95) compared to those with genetically lower TT and higher SHBG. No association was observed in groups with only high TT or only low SHBG.
Conclusion:
Our findings suggest that the interplay between TT and SHBG is important in determining fracture risk, highlighting the potential clinical value of jointly assessing them to improve fracture risk stratification in men.
Related Concept Videos
01:26Testosterone: Functions and Regulation
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:17Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:40Bone Remodeling
01:20Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
01:27Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...